SCOPUS 정보 검색 플랫폼

Volumn 8, Issue 1, 2002, Pages 95-102

Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: A pilot study

(9) Freyer, Gilles a Hennebert, Philippe a Brassinne, Christiane a De Valeriola, Dominique a Awada, Ahmad a Gil, Thierry a Kerger, Joseph a Selleslags, Jean a Piccart, Martine a

a JULES BORDET INSTITUTE (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; DOCETAXEL;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; NEUTROPENIA; NEUTROPHIL; PATIENT MONITORING; PILOT STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AMIFOSTINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NEUTROPHILS; PACLITAXEL; PILOT PROJECTS; SURVIVAL RATE; TAXOIDS; VOMITING;

EID: 0036152319 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (6)

References (25)

1
- 0032949449
- Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy
- 304 Study Group
- (1999) J. Clin. Oncol. , vol.17 , pp. 1413-1424
- Nabholtz, J.M.¹ Senn, H.J.² Bezwoda, W.R.³ Melnychuk, D.⁴ Deschenes, L.⁵ Douma, J.⁶ Vandenberg, T.A.⁷ Rapoport, B.⁸ Rosso, R.⁹ Trillet-Lenoir, V.¹⁰ Drbal, J.¹¹ Molino, A.¹² Nortier, J.W.¹³ Richel, D.J.¹⁴ Nagykalnai, T.¹⁵ Siedlecki, P.¹⁶ Wilking, N.¹⁷ Genot, J.Y.¹⁸ Hupperets, P.S.¹⁹ Pannuti, F.²⁰ more..

2
- 0032787785
- Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
- The 303 Study Group
- (1999) J. Clin. Oncol. , vol.17 , pp. 2341-2354
- Chan, S.¹ Friedrichs, K.² Noel, D.³ Pinter, T.⁴ Van Belle, S.⁵ Vorobiof, D.⁶ Duarte, R.⁷ Gil, M.⁸ Bodrogi, I.⁹ Murray, E.¹⁰ Yelle, L.¹¹ Von Minckwitz, G.¹² Korec, S.¹³ Simmonds, P.¹⁴ Buzzi, F.¹⁵ Gonzalez Mancha, R.¹⁶ Richardson, G.¹⁷ Walpole, E.¹⁸ Ronzoni, M.¹⁹ Murawsky, M.²⁰ Alakl, M.²¹ Riva, A.²² more..

3
- 0034095853
- Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
- The TAX 320 Non-Small Cell Lung Cancer Study Group
- (2000) J. Clin. Oncol. , vol.18 , pp. 2354-2362
- Fossella, F.V.¹ DeVore, R.² Kerr, R.N.³ Crawford, J.⁴ Natale, R.R.⁵ Dunphy, F.⁶ Kalman, L.⁷ Miller, V.⁸ Lee, J.S.⁹ Moore, M.¹⁰ Gandara, D.¹¹ Karp, D.¹² Vokes, E.¹³ Kris, M.¹⁴ Kim, Y.¹⁵ Gamza, F.¹⁶ Hammershaimb, L.¹⁷

4
- 0034069620
- Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
- (2000) J. Clin. Oncol. , vol.18 , pp. 2095-2103
- Shepherd, F.A.¹ Dancey, J.² Ramlau, R.³ Mattson, K.⁴ Gralla, R.⁵ O’Rourke, M.⁶ Levitan, N.⁷ Gressot, L.⁸ Vincent, M.⁹ Burkes, R.¹⁰ Coughlin, S.¹¹ Kim, Y.¹² Berille, J.¹³

5
- 0029125508
- Docetaxel
- (1995) J. Clin. Oncol. , vol.13 , pp. 2643-2655
- Cortes, J.E.¹ Pazdur, R.²

6
- 0032872127
- American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
- (1999) J. Clin. Oncol. , vol.17 , pp. 3333-3355
- Hensley, M.L.¹ Schuchter, L.M.² Lindley, C.³ Meropol, N.J.⁴ Cohen, G.I.⁵ Broder, G.⁶ Gradishar, W.J.⁷ Green, D.M.⁸ Langdon, R.J.⁹ Mitchell, R.B.¹⁰ Negrin, R.¹¹ Szatrowski, T.P.¹² Thigpen, J.T.¹³ Von Hoff, D.¹⁴ Wasserman, T.H.¹⁵ Winer, E.P.¹⁶ Pfister, D.G.¹⁷

7
- 0031427376
- Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained
- (1997) Eur. J. Cancer , vol.33 , pp. 1693-1698
- Taylor, C.W.¹ Wang, L.M.² List, A.F.³ Fernandes, D.⁴ Paine-Murrieta, G.D.⁵ Johnson, C.S.⁶ Capizzi, R.L.⁷

8
- 0029743651
- Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity
- (1996) Semin. Oncol. , vol.23 , pp. 58-63
- List, A.F.¹ Heaton, R.² Glinsmann-Gibson, B.³ Capizzi, R.L.⁴

9
- 0032887664
- Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer
- (1999) J. Clin. Oncol. , vol.17 , pp. 3038-3047
- Gelmon, K.¹ Eisenhauer, E.² Bryce, C.³ Tolcher, A.⁴ Mayer, L.⁵ Tomlinson, E.⁶ Zee, B.⁷ Blackstein, M.⁸ Tomiak, E.⁹ Yau, J.¹⁰ Batist, G.¹¹ Fisher, B.¹² Iglesias, J.¹³

10
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹

11
- 0034176245
- Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment
- (2000) Int. J. Radiat. Oncol. Biol. Phys. , vol.47 , pp. 13-47
- Trotti, A.¹ Byhardt, R.² Stetz, J.³ Gwede, C.⁴ Corn, B.⁵ Fu, K.⁶ Gunderson, L.⁷ McCormick, M.⁸ Morrisintegral, M.⁹ Rich, T.¹⁰ Shipley, W.¹¹ Curran, W.¹²

12
- 0026439301
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method
- (1992) J. Chromatogr. , vol.582 , pp. 273-278
- Vergniol, J.C.¹ Bruno, R.² Montay, G.³ Frydman, A.⁴

13
- 0008139484
- Adapt II user’s guide
- Los Angeles: Biomedical Simulations Resource
- (1997) Pharmacokinetic/Pharmacodynamic Systems Analysis Software
- D’Argenio, D.Z.¹ Schumitzky, A.²

14
- 0031982748
- Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer
- (1998) J. Clin. Oncol. , vol.16 , pp. 187-196
- Bruno, R.¹ Hille, D.² Riva, A.³ Vivier, N.⁴ Ten Bokkel Huinink, W.W.⁵ Van Osteroom, A.T.⁶ Kaye, S.B.⁷ Verweij, J.⁸ Fossella, F.V.⁹ Valero, V.¹⁰ Rigas, J.R.¹¹ Seidman, A.D.¹² Chevallier, B.¹³ Fumoleau, P.¹⁴ Burris, H.A.¹⁵ Ravdin, P.M.¹⁶ Sheiner, L.B.¹⁷

15
- 0018091195
- Application of Akaike’s Information Criterion in the evaluation of linear pharmacokinetic equations
- (1978) J. Pharmacokinet. Biopharm. , vol.6 , pp. 165-175
- Yamaoka, K.¹ Nakagawa, T.² Uno, T.³

16
- 0033956564
- A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors
- (2000) Clin. Cancer Res. , vol.6 , pp. 64-71
- Van Den Neste, E.¹ De Valeriola, D.² Kerger, J.³ Bleiberg, H.⁴ Kusenda, Z.⁵ Brassine, C.⁶ Bartholomeus, S.⁷ Selleslags, J.⁸ Hennebert, P.⁹ Wythouck, H.¹⁰ Cazenave, I.¹¹ Lefresne-Soulas, F.¹² Piccart, M.¹³

17
- 0008146467
- Phase I pharmacokinetic study of Taxotere administered as a weekly infusion
- (1992) Proc. Am. Assoc. Cancer Res. , vol.33 , pp. 261
- De Valeriola, D.¹ Brassine, C.² Piccart, M.³ Tomiak, E.⁴ Kerger, J.⁵ Awada, A.⁶ Ravoet, C.⁷ Lips, S.⁸ Auzannet, V.⁹ Le Bail, N.¹⁰ Bruno, R.¹¹ Klastersky, J.¹²

18
- 0000879287
- 14 radiolabelled Taxotere in cancer patients
- (1993) Proc. Am. Assoc. Cancer Res. , vol.34 , pp. 373
- De Valeriola, D.¹ Brassine, C.² Gaillard, C.³ Ketler, J.P.⁴ Tomiak, E.⁵ Van Vreckem, A.⁶ Frühling, J.⁷ Frydman, A.⁸ Kerger, J.⁹ Piccart, M.¹⁰ Chapelle, P.¹¹ Blanc, C.¹²

19
- 0033897266
- Docetaxel in combination with 5-FU in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: A phase I, dose-finding study
- (2000) Eur. J. Cancer , vol.36 , pp. 1773-1780
- Lortholary, A.¹ Maillard, P.² Delva, R.³ Boisdron-Celle, M.⁴ Perard, D.⁵ Vernillet, L.⁶ Besenval, M.⁷ Gamelin, E.⁸

20
- 0003747347
- NONMEM user’s guide
- San Francisco: University of California
- (1992) NONMEM Project Group
- Beal, S.L.¹ Sheiner, L.B.²

21
- 0028837575
- Early clinical studies with docetaxel
- (1995) Eur. J. Cancer , vol.31 , pp. S7-S10
- Aapro, M.¹ Bruno, R.²

22
- 0001482149
- Primary chemotherapy in breast cancer: Significantly enhanced clinical and pathological response with docetaxel
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19 , pp. 317
- Hutcheon, A.W.¹ Smith, I.C.² Heys, S.D.³

23
- 0029902007
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: Results of a randomized controlled trial in patients with advanced ovarian cancer
- (1996) J. Clin. Oncol. , vol.14 , pp. 2101-2112
- Kemp, G.¹ Rose, P.² Lurain, J.³

24
- 0022655609
- WR-2721 protects against the hematologic toxicity of cyclophosphamide: A controlled phase II trial
- (1996) J. Clin. Oncol. , vol.4 , pp. 584-588
- Glover, D.¹ Glick, J.² Weiler, C.³

25
- 0034092277
- Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: Additional chemotherapy enhances regression of residual cancer
- (2000) Med. Oncol. , vol.17 , pp. 135-143
- Koukourakis, M.I.¹ Giatromanolaki, A.² Kakolyris, S.³ Froudarakis, M.⁴ Georgoulias, V.⁵ Retalis, G.⁶ Bahlitzanakis, N.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.